OUR SPECIALTIES

BIOLOGICS

Critical Care

Octaplex® is a prothrombin complex concentrate (PCC) containing therapeutic and balanced levels of Factors II, VII, IX and X, as well as inhibitory proteins C and S. Octaplex® has been shown to provide rapid INR reversal within 10 minutes1, with a small volume (500 IU in 20 mL per vial) and short infusion time2.
Fibryga® is indicated for treatment of bleeding and perioperative prophylaxis in patients with congenital hypo or afibrinogenaemia with bleeding tendency. It can also be used as a complementary therapy to manage uncontrolled severe haemorrhage in patients with acquired hypofibrinogenaemia during surgical intervention.
Albunorm® is human albumin which is used for maintenance of colloid osmotic pressure, regulation of intravascular and extravascular fluid volume, with buffer effect and transport function in human plasma1.

Immunotherapy

Octagam® is a human normal immunoglobulin (IVIg) that is indicated for replacement therapy in patients with primary immunodeficiency syndromes, myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections, and children with congenital AIDS and recurrent infections. It is also used in immunomodulation of idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, in patients with Guillain Barré syndrome and Kawasaki disease.

Haematology

Octanate® 500 IU contains human coagulation factor VIII, and is indicated for treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency)1. It is naturally stabilised and protected by VWF, and is highly purified and efficacious2.
Nuwiq® is indicated for treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). It is a recombinant antihemophilic factor [blood coagulation factor VIII (Factor VIII)] used to treat Hemophilia A.